FDA Approved: PORTRAZZA — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved Portrazza (necitumumab) from Eli Lilly as an original application for first-line treatment of metastatic squamous non-small cell lung cancer in com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Portrazza (necitumumab)

Snippet

ORIG AP for PORTRAZZA (NECITUMUMAB)